Search the Newsreel

Earnings call transcript: Stryker beats Q2 2026 estimates but shares fall

Stryker (SYK) reported better-than-expected Q2 2026 results with adjusted EPS of $3.69 and revenue of $6.6 billion, surpassing analyst estimates. Despite the beat, shares fell 9.23% in after-hours trading, reflecting investor concern over narrowed full-year guidance and execution risks, particularly supply chain issues following …

Stryker (SYK) Q2 Earnings and Revenues Beat Estimates

Stryker (SYK) reported second-quarter earnings of $3.69 per share, surpassing the Zacks Consensus Estimate of $3.46, and revenues of $6.59 billion, beating the estimate by 0.48%. Despite outperforming estimates in three of the last four quarters, the stock has underperformed the S&P 500 year-to-date. …

Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops

Stryker (NYSE:SYK) reported Q2 CY2026 sales of $6.59 billion, meeting Wall Street estimates with a 9.4% year-over-year increase, and non-GAAP EPS of $3.69, beating consensus by 5.8%. Despite meeting revenue expectations and beating EPS, the stock dropped 7.5% immediately after the announcement, indicating investor …

Stryker posts Q2 beats, narrows guidance after progress on cyberattack recovery

Stryker reported second-quarter financial results that exceeded Wall Street expectations, with profits of $1.28 billion and sales of $6.59 billion. Despite the strong performance, the company narrowed its full-year 2026 guidance, expecting organic sales growth between 8.3% and 9.3% and adjusted EPS between $14.95 …

Stryker Q2 Adjusted Earnings, Revenue Rise

This article reports on Stryker's second-quarter financial results, highlighting increases in both adjusted earnings and revenue. This indicates positive financial performance for the company during the quarter.

Stryker stock tumbles 8% despite topping Q2 estimates as guidance narrowed

Stryker (NYSE:SYK) reported strong Q2 results, exceeding analyst expectations for both EPS and revenue, with significant organic sales growth. However, the medical technology company's stock fell 8.7% after it narrowed its full-year guidance for organic net sales growth and adjusted EPS. This indicates that …

Stryker Logs Higher Profit, Revenue Amid Cyberattack Recovery

Stryker reported a significant increase in profit and revenue for the second quarter, demonstrating recovery from a March cyberattack. The medical technology company posted profits of $1.28 billion, or $3.30 per share, up from $884 million, or $2.29 per share, a year prior. Stryker …

Stryker Corporation (NYSE: SYK) reports higher Q2 EPS and narrows 2026 outlook

Stryker Corporation reported strong second-quarter 2026 results, with net sales of $6.6 billion, a 9.4% increase, and organic net sales growth of 9.0%. The company achieved a reported diluted EPS of $3.30, up 44.1%, and an adjusted diluted EPS of $3.69, a 17.9% increase. …

Stryker posts Q2 2026 sales $6.59B, adjusted EPS $3.69 and operating margin 27.4%

Stryker (SYK) reported strong second-quarter 2026 results, with net sales reaching $6.59 billion, marking a 9.4% year-over-year increase. The company's adjusted diluted EPS rose by 17.9% to $3.69, and its adjusted operating income margin improved to 27.4%. Stryker also narrowed its full-year 2026 guidance …

Stryker reports second quarter 2026 operating results

Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased9.4% to $6.6 billionOrganic net sales increased9.0%Reported operating income margin of 25.2%Adjusted operating income margin(1)increased170 bps to27.4%Reported EPS increased44.1% …

Stryker Narrows 2026 Organic Sales Growth Outlook to 8.3%-9.3%

Stryker (NYSE: SYK) reported strong second-quarter 2026 results with net sales rising 9.4% to $6.6 billion and organic net sales growth of 9.0%. Despite positive financial metrics including a 44.1% increase in reported EPS, the company narrowed its full-year 2026 organic net sales growth …

Stryker Corp. stock outperforms competitors despite losses on the day

Stryker Corp. (SYK) shares decreased by 1.20% to $348.04 on Thursday, despite a generally favorable trading session where the S&P 500 Index and Dow Jones Industrial Average both saw gains. This fall ended a five-day winning streak for the stock. Despite the daily loss, …

Stryker Corp (SYK) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Stryker Corp (SYK), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. According to the analysis, SYK's stock is currently trading between resistance at $367.65 and support …

Stryker Corp (SYK) Financial Health: Profitability & Balance Sheet Analysis

Stryker Corp (SYK) currently holds a financial score of 8.50, ranking 30th within the Healthcare Equipment & Supplies industry. The company exhibits stable financial health and high operating efficiency. Its recent quarterly revenue increased by 2.63% year-over-year to $6.02 billion, while net profit saw …

STRYKER ($SYK) Releases Q2 2026 Earnings

Apple, Amazon, Stryker, and more set to report earnings Thursday By Investing.com

Thursday marks a busy day for earnings season with major companies like Apple, Amazon, and Stryker, along with numerous others from various sectors, scheduled to release their quarterly results. The report provides detailed estimated EPS and revenue for dozens of companies reporting before and …

Stryker (NYSE:SYK) Raised to Strong-Buy at UBS Group

UBS Group upgraded Stryker (NYSE:SYK) to a "strong-buy" rating. Despite the upgrade, the company recently missed quarterly earnings and revenue estimates, reporting $2.60 EPS against an expected $2.98 and $6.02 billion in revenue versus a $6.34 billion forecast. Insider sales totaling over $100 million …

Stryker Corporation $SYK Shares Sold by California State Teachers Retirement System

California State Teachers Retirement System reduced its stake in Stryker Corporation by 2.2% in the first quarter, selling 11,784 shares but still holding 533,564 shares valued at $175.3 million. Despite this, other institutional investors have increased their holdings, with institutional ownership collectively at 77.09%. …

Stryker Corp (SYK) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Stryker Corp (SYK), noting its current valuation score of 9.39 and ranking within the Healthcare Equipment & Supplies industry. It details the company's current P/E ratio relative to its recent high and low. The report also indicates …

Stryker (SYK) Q2 Earnings Report Preview: What To Look For

Stryker (SYK) is set to report its Q2 earnings this Thursday, with market expectations for revenue growth of 9.1% year-on-year, a slowdown from the previous year's 11.1% increase. Last quarter, Stryker missed revenue and EPS estimates. Investors should note that analysts have largely reconfirmed …

Is Stryker (SYK) Stock Rich Or Reasonable After Its Robotics Launch?

Stryker (SYK) stock presents a mixed valuation picture. While a Discounted Cash Flow (DCF) analysis suggests a 15.0% upside due to expected cash flow growth, traditional earnings multiples indicate the stock is expensive, trading at a P/E of 39.8x compared to an industry average …

Stryker Corp. stock underperforms Tuesday when compared to competitors despite daily gains

Stryker Corp. shares rose 2.93% on Tuesday, closing at $346.60, marking its fourth consecutive day of gains. Despite this increase, the stock underperformed compared to the broader market, as the S&P 500 Index rose 0.21% and the Dow Jones Industrial Average gained 1.03%. The …

Stryker (SYK) Launches Mako RPS To Bring Robotic Knee Surgery To More Surgeons

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Stryker has introduced Mako RPS, a robotic handheld system for total knee replacement, expanding its Mako robotics portfolio. The launch extends robotic assistance to …

UBS reiterates Stryker stock Buy rating with $400 price target

UBS has reiterated a Buy rating on Stryker Corp. (NYSE:SYK) with a price target of $400.00, suggesting a potential 19% upside from its current stock price. The medical technology company, which has consistently raised its dividend for 16 years, is also focusing on its …

Stryker Corporation $SYK Shares Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp increased its holdings in Stryker Corporation (NYSE:SYK) by 25.4% during Q1, bringing its total to 17,766 shares valued at $5.84 million. Despite this institutional buying, the company missed analyst earnings and revenue expectations for the quarter, though revenue saw a 2.6% …

PAHC vs. SYK: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There …

Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS

Wall Street analysts expect Stryker (SYK) to post quarterly earnings of $3.46 per share in its upcoming report, which indicates a year-over-year increase of 10.5%. Revenues are expected to be $6.56 billion, up 8.9% from the year-ago quarter. Over the last 30 days, there …

Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders

Stryker (SYK) is expected to show recovery in its second-quarter 2026 results from a cyber incident that disrupted its first-quarter shipments. Analysts anticipate healthy underlying performance driven by procedural demand and robotic surgery adoption, with earnings projected to increase by 10.5% and revenues by …

Stryker Corp (SYK) Cash Flow

This article provides comprehensive quarterly and annual cash flow statements for Stryker Corp (SYK), including operating, investing, and financing cash flows, from Q1 2012 to Q1 2026. It also includes key financial metrics like net income, capital expenditures, and free cash flow, alongside explanations …

Stryker stock trades near highs as orthopedic demand supports revenue growth

Stryker's stock is trading near its annual highs, driven by consistent demand for orthopedic and medical technology products. The company reported double-digit revenue growth and strong profitability in Q1 2024, with total revenue reaching approximately $5.24 billion, a 9.7% increase year-on-year, and diluted EPS …

Stryker Corp (SYK) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Stryker Corp (SYK), identifying its major institutional and individual shareholders, including Vanguard Capital Management and John W. Brown. It also breaks down shareholder types by proportion, such as investment advisors and banks, and provides a historical overview …

Stryker Corporation Revenue Breakdown – NYSE:SYK

Court refuses Stryker's non-compete bid to block former sales rep

The Supreme Court of Queensland refused Stryker Australia's request for an interim injunction to prevent a former sales executive from joining a competitor. The court found that Stryker's non-compete clause, which was broad in scope, likely exceeded legitimate business interests. The judge also weighed …

SYK|Stryker Corp|Price:330.290|Chg%:+11.320

Stryker Corp (SYK) saw its stock price move up by 3.55% on July 24th, closing at 330.290 USD. The medical technology company, which offers products and services across MedSurg, Neurotechnology, and Orthopaedics, has strong fundamentals and high growth potential. Analysts currently rate the stock …

Stryker stock holds gains as medical device growth supports valuation

Stryker stock is performing well, trading near its 52-week high, supported by rising revenue and earnings driven by its medical technology portfolio. The company reported full-year net sales of $22.3 billion in fiscal 2024, an increase from $20.3 billion in 2023, with significant growth …

The Bull Case For Stryker (SYK) Could Change Following Mako RPS Handheld Knee Robotics Launch - Learn Why

Stryker recently launched its Mako RPS Handheld Knee Robotics system in the US, expanding its Mako ecosystem for total knee replacements. This new system, designed for wider adoption across surgeons and care settings, is a positive development for Stryker's investment narrative, reinforcing its focus …